Company intelligence / Profile preview

Somite Therapeutics

Boston, Massachusetts, USAprnewswire.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Somite Therapeutics is leveraging advanced AI models to develop protocols for producing human tissues from stem cells. Their lead programs are in preclinical development, targeting Duchenne muscular dystrophy and metabolic diseases. The company’s proprietary AlphaStem platform enables rapid discovery and optimization of cell differentiation protocols, aiming to accelerate the creation of new cell-based therapies[4][5][6].

Therapeutic areas
Metabolic DisordersRheumatologyRare Diseases
Modalities
Cell therapy (including cell replacement therapies)Induced pluripotent stem cells (iPSC)
Industry
Biotech
02

Drug pipeline

2 assets

SMT-B01

Preclinical

1 more asset in the full pipeline.

Request access →
03

Partnerships

OmniaBio Inc. (for GMP manufacturing and clinical translation)[5]Astellas Venture Management (investor/board observer)[3]Montage Ventures (investor/board observer)[3]

Beyond the preview

Go deeper on Somite Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Somite Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call